Media Library
Stay up-to-date on our latest news and find resources for journalists.
Stay up-to-date on our latest news and find resources for journalists.
Oct 29, 2024
Clover Announces Positive Clinical Data for RSV Vaccine Candidate SCB-1019 Compared Head-to-Head Versus GSK’s AREXVY
Jun 18, 2024
Clover Announces Positive Preliminary PhaseⅠResults for Bivalent RSV Vaccine Candidate SCB-1019 in Older Adults
Apr 8, 2024
Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young Adult Cohort
Dec 29, 2023
Clover Announces Positive PhaseⅠResults for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT)
Picture: Employees prepare Clover's COVID-19 vaccine for shipment
Picture: Clover's COVID-19 vaccine
Picture: Changxing facility employees prepare Clover's COVID-19 vaccine for shipment
Picture: Equipment at Clover's Changxing facility
Picture: Equipment at Clover's Changxing facility
Picture: Laboratory at Clover's Changxing facility
Picture: Clover's Changxing manufacturing facility
Video: Clover's Changxing manufacturing facility
